KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Intangibles (2016 - 2025)

Historic Intangibles for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $5.6 billion.

  • Abbott Laboratories' Intangibles fell 2385.75% to $5.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 billion, marking a year-over-year decrease of 2385.75%. This contributed to the annual value of $6.6 billion for FY2024, which is 2459.44% down from last year.
  • Abbott Laboratories' Intangibles amounted to $5.6 billion in Q3 2025, which was down 2385.75% from $5.9 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Intangibles peaked at $27.8 billion during Q2 2021, and registered a low of $5.6 billion during Q3 2025.
  • Moreover, its 5-year median value for Intangibles was $9.8 billion (2023), whereas its average is $12.8 billion.
  • As far as peak fluctuations go, Abbott Laboratories' Intangibles surged by 109.09% in 2021, and later plummeted by 6387.73% in 2023.
  • Over the past 5 years, Abbott Laboratories' Intangibles (Quarter) stood at $12.7 billion in 2021, then decreased by 17.94% to $10.5 billion in 2022, then decreased by 15.68% to $8.8 billion in 2023, then fell by 24.59% to $6.6 billion in 2024, then decreased by 15.78% to $5.6 billion in 2025.
  • Its last three reported values are $5.6 billion in Q3 2025, $5.9 billion for Q2 2025, and $6.3 billion during Q1 2025.